Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan Carlos Almagro is active.

Publication


Featured researches published by Juan Carlos Almagro.


mAbs | 2016

Structural diversity in a human antibody germline library.

Alexey Teplyakov; Galina Obmolova; Thomas J. Malia; Jinquan Luo; Salman Muzammil; Raymond Sweet; Juan Carlos Almagro; Gary L. Gilliland

ABSTRACT To support antibody therapeutic development, the crystal structures of a set of 16 germline variants composed of 4 different kappa light chains paired with 4 different heavy chains have been determined. All four heavy chains of the antigen-binding fragments (Fabs) have the same complementarity-determining region (CDR) H3 that was reported in an earlier Fab structure. The structure analyses include comparisons of the overall structures, canonical structures of the CDRs and the VH:VL packing interactions. The CDR conformations for the most part are tightly clustered, especially for the ones with shorter lengths. The longer CDRs with tandem glycines or serines have more conformational diversity than the others. CDR H3, despite having the same amino acid sequence, exhibits the largest conformational diversity. About half of the structures have CDR H3 conformations similar to that of the parent; the others diverge significantly. One conclusion is that the CDR H3 conformations are influenced by both their amino acid sequence and their structural environment determined by the heavy and light chain pairing. The stem regions of 14 of the variant pairs are in the ‘kinked’ conformation, and only 2 are in the extended conformation. The packing of the VH and VL domains is consistent with our knowledge of antibody structure, and the tilt angles between these domains cover a range of 11 degrees. Two of 16 structures showed particularly large variations in the tilt angles when compared with the other pairings. The structures and their analyses provide a rich foundation for future antibody modeling and engineering efforts.


mAbs | 2018

Structural insights into humanization of anti-tissue factor antibody 10H10

Alexey Teplyakov; Galina Obmolova; Thomas J. Malia; Gopalan Raghunathan; Christian Martinez; Johan Fransson; Wilson Edwards; Judith Connor; Matthew Husovsky; Heena Beck; Ellen Chi; Sandra Fenton; Hong Zhou; Juan Carlos Almagro; Gary L. Gilliland

ABSTRACT Murine antibody 10H10 raised against human tissue factor is unique in that it blocks the signaling pathway, and thus inhibits angiogenesis and tumor growth without interfering with coagulation. As a potential therapeutic, the antibody was humanized in a two-step procedure. Antigen-binding loops were grafted onto selected human frameworks and the resulting chimeric antibody was subjected to affinity maturation by using phage display libraries. The results of humanization were analyzed from the structural perspective through comparison of the structure of a humanized variant with the parental mouse antibody. This analysis revealed several hot spots in the framework region that appear to affect antigen binding, and therefore should be considered in human germline selection. In addition, some positions in the Vernier zone, e.g., residue 71 in the heavy chain, that are traditionally thought to be crucial appear to tolerate amino acid substitutions without any effect on binding. Several humanized variants were produced using both short and long forms of complementarity-determining region (CDR) H2 following the difference in the Kabat and Martin definitions. Comparison of such pairs indicated consistently higher thermostability of the variants with short CDR H2. Analysis of the binding data in relation to the structures singled out the ImMunoGeneTics information system® germline IGHV1-2*01 as dubious owing to two potentially destabilizing mutations as compared to the other alleles of the same germline and to other human germlines.


Frontiers in Bioscience | 2008

Humanization of antibodies

Juan Carlos Almagro; Johan Fransson


Archive | 2008

Design and generation of human de novo pix phage display libraries via fusion to pix or pvii, vectors, antibodies and methods

Ping Tsui; Lei Shi; Jin Lu; John Wheeler; Brian Whitaker; Lionella Borozdina-Birch; Juan Carlos Almagro; Bernard Amegadzie; Mark Tornetta; Ramachandra Reddy; David M. Knight; Jinquan Luo; Raymond Sweet


Archive | 2010

Il-17a antagonists

Michael Naso; Raymond Sweet; Jinquan Luo; Sheng-Jiun Wu; Merle Elloso; Daniela Della Ducata; Robert Rauchenberger; Mark Rutz; Juan Carlos Almagro; Susann Taudte; Bingyuan Wu; Galina Obmolova; Thomas J. Malia


Archive | 2010

Methods of affinity maturing antibodies

Juan Carlos Almagro; Johan Fransson; Gopalan Raghunathan


Archive | 2010

IL-17A antibodies

Juan Carlos Almagro; Daniela Della Ducata; Merle Elloso; Jinquan Luo; Thomas J. Malia; Michael Naso; Galina Obmolova; Robert Rauchenberger; Mark Rutz; Raymond Sweet; Susann Taudte; Bingyuan Wu; Sheng-Jiun Wu


Archive | 2013

Human anti-CD27 antibodies, methods and uses

John Chen; Johan Fransson; Natalie Fursov; Damon Hamel; Thomas J. Malia; Galina Obmolova; Tatiana Ort; Michael Rycyzyn; Michael Scully; Raymond Sweet; Alexey Teplyakov; John Wheeler; Juan Carlos Almagro


Archive | 2012

Human tissue factor antibody and uses thereof

Juan Carlos Almagro; Glenn Mark Anderson; Ellen Chi; Christian Martinez; Gopalan Raghunathan; Ronald V. Swanson; Alexey Teplyakov; Kam-Fai Tse; Sheng-Jiun Wu; Hong Mimi Zhou


Archive | 2011

Human Oncostatin M Antibodies and Methods of Use

Juan Carlos Almagro; William Dubell; Johan Fransson; Jose Pardinas

Collaboration


Dive into the Juan Carlos Almagro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John Chen

Janssen Pharmaceutica

View shared research outputs
Researchain Logo
Decentralizing Knowledge